NATCO PHARMA LTD SCREENER.

IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Trailing Best Case Worst Case
Sales 264.66 307.44 348.35 435.68 557.85 622.34 715.55 1,059.20 1,958.00 2,091.30 2,299.00 2,990.03 2,319.63
Expenses 196.84 221.54 256.60 324.30 402.10 435.75 489.99 778.50 1,266.00 1,162.90 1,256.40 1,634.05 1,535.58
Operating Profit 67.82 85.90 91.75 111.38 155.75 186.59 225.56 280.70 692.00 928.40 1,042.60 1,355.98 784.05
Other Income 11.00 3.53 0.78 9.51 1.53 15.71 1.46 12.90 13.20 39.40 119.70 - -
Depreciation 10.35 13.87 14.35 15.41 19.84 26.79 42.46 50.20 53.60 65.50 76.60 76.60 76.60
Interest 15.05 14.69 14.20 22.96 25.12 34.06 30.13 21.90 17.50 14.70 16.30 16.30 16.30
Profit before tax 53.42 60.87 63.98 82.52 112.33 141.45 154.41 221.50 634.10 887.60 1,069.40 1,263.08 691.15
Tax 10.68 13.21 11.86 20.39 34.19 31.26 1.48 45.00 139.30 189.40 229.60 21% 21%
Net profit 42.74 47.66 52.12 62.13 78.14 110.19 152.93 176.50 494.80 698.20 839.80 991.90 542.76
EPS 3.05 3.39 3.70 3.99 4.98 6.66 9.20 10.13 28.39 37.84 46.20 54.57 29.86
Price to earning 3.98 9.45 15.01 19.00 17.78 22.69 49.08 44.71 31.96 20.96 11.04 27.17 11.04
Price 12.13 32.00 55.57 75.79 88.57 151.16 451.67 453.05 907.30 793.09 510.20 1,482.56 329.74

RATIOS:
Dividend Payout 8.19% 11.81% 10.80% 15.05% 16.06% 15.01% 10.86% 12.32% 23.81% 21.80%
OPM 25.63% 27.94% 26.34% 25.56% 27.92% 29.98% 31.52% 26.50% 35.34% 44.39% 45.35%

TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST

Sales Growth 25.82% 29.18% 30.25% 42.97% 9.93% 42.97% 9.93%
OPM 33.80% 34.68% 35.88% 37.21% 45.35% 45.35% 33.80%
Price to Earning 22.33 27.15 30.07 27.17 11.04 27.17 11.04
NATCO PHARMA LTD SCREENER.IN

Narration Sep-16 Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Sep-18 Dec-18
Sales 448.60 657.50 542.20 413.60 408.40 540.30 729.00 515.70 522.40 531.90
Expenses 340.50 395.50 300.90 273.00 283.20 254.00 352.70 290.60 291.60 321.50
Operating Profit 108.10 262.00 241.30 140.60 125.20 286.30 376.30 225.10 230.80 210.40
Other Income 3.00 6.10 -0.80 2.70 4.90 11.20 20.60 35.70 39.70 23.70
Depreciation 13.90 13.50 13.20 14.80 15.80 17.10 17.80 18.30 20.00 20.50
Interest 4.20 4.40 5.90 3.80 4.10 4.10 2.70 2.70 3.70 7.20
Profit before tax 93.00 250.20 221.40 124.70 110.20 276.30 376.40 239.80 246.80 206.40
Tax 23.50 53.10 44.10 27.30 22.80 59.00 80.30 51.20 53.70 44.40
Net profit 69.50 197.10 177.30 97.40 87.40 217.30 296.10 188.60 193.10 162.00

OPM 24% 40% 45% 34% 31% 53% 52% 44% 44% 40%
NATCO PHARMA LTD SCREENER.IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
Equity Share Capital 28.04 28.15 28.15 31.15 31.37 33.07 33.23 34.80 34.90 36.90
Reserves 228.36 273.28 318.76 436.32 506.21 699.83 845.76 1,301.50 1,664.80 3,088.50
Borrowings 126.20 119.30 219.88 258.64 335.55 237.17 308.85 110.20 220.80 173.00
Other Liabilities 122.99 112.01 131.20 163.06 187.57 210.23 207.00 402.30 427.30 438.70
Total 505.59 532.74 697.99 889.17 1,060.70 1,180.30 1,394.84 1,848.80 2,347.80 3,737.10

Net Block 201.15 233.20 254.15 301.81 470.56 528.98 572.74 705.60 829.00 1,015.30
Capital Work in Progress 46.96 39.60 75.98 164.43 78.37 92.94 100.77 211.90 336.20 480.00
Investments 59.10 79.23 71.19 74.89 77.57 88.90 131.27 93.80 94.80 149.60
Other Assets 198.38 180.71 296.67 348.04 434.20 469.48 590.06 837.50 1,087.80 2,092.20
Total 505.59 532.74 697.99 889.17 1,060.70 1,180.30 1,394.84 1,848.80 2,347.80 3,737.10

Working Capital 75.39 68.70 165.47 184.98 246.63 259.25 383.06 435.20 660.50 1,653.50
Debtors 57.17 54.63 70.37 93.34 126.46 115.85 188.96 255.80 468.90 606.00
Inventory 64.67 65.62 93.02 97.28 128.32 161.97 198.35 351.90 336.90 425.80

Debtor Days 78.84 64.86 73.73 78.20 82.74 67.95 96.39 88.15 87.41 105.77
Inventory Turnover 4.09 4.69 3.74 4.48 4.35 3.84 3.61 3.01 5.81 4.91

Return on Equity 17% 16% 15% 13% 15% 15% 17% 13% 29% 22%
Return on Capital Emp 19% 16% 16% 17% 19% 17% 18% 39% 35%
NATCO PHARMA LTD SCREENER.IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
Cash from Operating Activity 49.74 68.78 32.29 68.01 70.02 171.79 124.55 189.90 329.80 476.40
Cash from Investing Activity -66.54 -53.59 -83.41 -128.57 -123.41 -130.64 -147.95 -248.10 -290.60 -1,131.10
Cash from Financing Activity 17.15 -31.25 79.50 61.97 29.18 -40.96 22.80 151.40 -45.60 652.00
Net Cash Flow 0.35 -16.06 28.38 1.41 -24.21 0.19 -0.59 93.20 -6.40 -2.70
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.

After customization, you can upload this back on Screener.

Upload on: https://www.screener.in/excel/

Download your customized workbooks now onwards.

Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: screener.feedback@dalal-street.in
COMPANY NAME NATCO PHARMA LTD
LATEST VERSION 2.10 PLEASE
CURRENT VERSION 2.10

META
Number of shares 18.18
Face Value 2
Current Price 510.2
Market Capitalization 9273.5

PROFIT & LOSS

Report Date Mar-09 Mar-10 Mar-11 Mar-12
Sales 264.66 307.44 348.35 435.68
Raw Material Cost 96.60 94.07 112.74 133.20
Change in Inventory 7.10 -3.35 11.76 -1.08
Power and Fuel 15.48 14.80 21.18 26.32
Other Mfr. Exp 17.42 23.44 28.99 34.78
Employee Cost 35.47 42.03 53.44 67.13
Selling and admin 35.29 34.19 44.39 55.10
Other Expenses 3.68 9.66 7.62 6.69
Other Income 11.00 3.53 0.78 9.51
Depreciation 10.35 13.87 14.35 15.41
Interest 15.05 14.69 14.20 22.96
Profit before tax 53.42 60.87 63.98 82.52
Tax 10.68 13.21 11.86 20.39
Net profit 42.74 47.66 52.12 62.13
Dividend Amount 3.50 5.63 5.63 9.35

Quarters
Report Date Sep-16 Dec-16 Mar-17 Jun-17
Sales 448.60 657.50 542.20 413.60
Expenses 340.50 395.50 300.90 273.00
Other Income 3.00 6.10 -0.80 2.70
Depreciation 13.90 13.50 13.20 14.80
Interest 4.20 4.40 5.90 3.80
Profit before tax 93.00 250.20 221.40 124.70
Tax 23.50 53.10 44.10 27.30
Net profit 69.50 197.10 177.30 97.40
Operating Profit 108.1 262 241.3 140.6

BALANCE SHEET
Report Date Mar-09 Mar-10 Mar-11 Mar-12
Equity Share Capital 28.04 28.15 28.15 31.15
Reserves 228.36 273.28 318.76 436.32
Borrowings 126.2 119.3 219.88 258.64
Other Liabilities 122.99 112.01 131.2 163.06
Total 505.59 532.74 697.99 889.17
Net Block 201.15 233.2 254.15 301.81
Capital Work in Progress 46.96 39.6 75.98 164.43
Investments 59.1 79.23 71.19 74.89
Other Assets 198.38 180.71 296.67 348.04
Total 505.59 532.74 697.99 889.17
Receivables 57.17 54.63 70.37 93.34
Inventory 64.67 65.62 93.02 97.28
Cash & Bank 20.09 3.5 30.97 33.7
No. of Equity Shares 28040827 28147952 28147952 31147952
New Bonus Shares
Face value 10 10 10 10

CASH FLOW:
Report Date Mar-09 Mar-10 Mar-11 Mar-12
Cash from Operating Activity 49.74 68.78 32.29 68.01
Cash from Investing Activity -66.54 -53.59 -83.41 -128.57
Cash from Financing Activity 17.15 -31.25 79.50 61.97
Net Cash Flow 0.35 -16.06 28.38 1.41

PRICE: 12.13 32.00 55.57 75.79

DERIVED:
Adjusted Equity Shares in Cr 14.02 14.07 14.07 15.57
 PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18

557.85 622.34 715.55 1,059.20 1,958.00 2,091.30
186.21 166.70 179.46 304.10 589.50 413.20
21.25 15.97 8.76 47.80 16.70 24.70
36.98 40.69 40.49 43.70 50.50 56.10
44.41 53.09 50.09 113.40 101.10 120.20
85.36 94.22 116.19 171.90 232.10 312.20
62.49 88.29 98.18 170.30 268.70 248.90
7.90 8.73 14.34 22.90 40.80 37.00
1.53 15.71 1.46 12.90 13.20 39.40
19.84 26.79 42.46 50.20 53.60 65.50
25.12 34.06 30.13 21.90 17.50 14.70
112.33 141.45 154.41 221.50 634.10 887.60
34.19 31.26 1.48 45.00 139.30 189.40
78.14 110.19 152.93 176.50 494.80 698.20
12.55 16.54 16.61 21.75 117.79 152.21

Sep-17 Dec-17 Mar-18 Jun-18 Sep-18 Dec-18

408.40 540.30 729.00 515.70 522.40 531.90
283.20 254.00 352.70 290.60 291.60 321.50
4.90 11.20 20.60 35.70 39.70 23.70
15.80 17.10 17.80 18.30 20.00 20.50
4.10 4.10 2.70 2.70 3.70 7.20
110.20 276.30 376.40 239.80 246.80 206.40
22.80 59.00 80.30 51.20 53.70 44.40
 87.40 217.30 296.10 188.60 193.10 162.00
125.2 286.3 376.3 225.1 230.8 210.4

Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18

31.37 33.07 33.23 34.8 34.9 36.9
506.21 699.83 845.76 1301.5 1664.8 3088.5
335.55 237.17 308.85 110.2 220.8 173
187.57 210.23 207 402.3 427.3 438.7
1,060.70 1,180.30 1,394.84 1,848.80 2,347.80 3,737.10
470.56 528.98 572.74 705.6 829 1015.3
78.37 92.94 100.77 211.9 336.2 480
77.57 88.9 131.27 93.8 94.8 149.6
434.2 469.48 590.06 837.5 1087.8 2092.2
1,060.70 1,180.30 1,394.84 1,848.80 2,347.80 3,737.10
126.46 115.85 188.96 255.80 468.90 606.00
128.32 161.97 198.35 351.9 336.9 425.8
7.5 7.7 7.19 40.2 25.1 172.1
31373074 33073074 33234849 174174245 174307800 184493400

10 10 10 2 2 2

Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18

70.02 171.79 124.55 189.90 329.80 476.40
-123.41 -130.64 -147.95 -248.10 -290.60 -1,131.10
29.18 -40.96 22.80 151.40 -45.60 652.00
-24.21 0.19 -0.59 93.20 -6.40 -2.70

88.57 151.16 451.67 453.05 907.30 793.09

15.69 16.54 16.62 17.42 17.43 18.45

 YTD Avg Profit YTD forecast YTD Profit
Last YTD Profit Trailing 12Profit forecast variance Forecast Last YTD PE
698.2 839.8 724.933333333 -0.1584513518 782.366666667 20.956677
 YTD Profit
Trailing PE Growth
11.0425101 12.054808